The Beauty Health Company (NASDAQ:SKIN) Given Average Rating of “Reduce” by Analysts

The Beauty Health Company (NASDAQ:SKIN) has received a consensus recommendation of “Reduce” from the twelve ratings firms that are covering the stock, Marketbeat.com reports. Three research analysts have rated the stock with a sell rating, seven have given a hold rating and two have assigned a buy rating to the company. The average 1 year price target among brokers that have updated their coverage on the stock in the last year is $6.29.

A number of brokerages have recently weighed in on SKIN. DA Davidson reissued a “buy” rating and set a $5.00 price target on shares of Beauty Health in a research report on Monday, May 13th. Stifel Nicolaus reissued a “hold” rating and set a $4.00 price target (up from $3.00) on shares of Beauty Health in a research report on Wednesday, March 13th. Piper Sandler reduced their price target on shares of Beauty Health from $3.00 to $2.50 and set an “underweight” rating on the stock in a research report on Friday, May 10th. TD Cowen reduced their price target on shares of Beauty Health from $4.00 to $3.00 and set a “hold” rating on the stock in a research report on Monday, May 13th. Finally, Canaccord Genuity Group lifted their price target on shares of Beauty Health from $3.00 to $4.00 and gave the stock a “hold” rating in a research report on Thursday, March 14th.

Institutional Investors Weigh In On Beauty Health

Several institutional investors have recently added to or reduced their stakes in SKIN. 180 Wealth Advisors LLC bought a new stake in Beauty Health in the 3rd quarter valued at $172,000. M&T Bank Corp increased its stake in Beauty Health by 6.8% in the 3rd quarter. M&T Bank Corp now owns 125,706 shares of the company’s stock valued at $756,000 after buying an additional 8,036 shares during the last quarter. Olympiad Research LP acquired a new stake in Beauty Health in the 3rd quarter valued at $287,000. Fox Run Management L.L.C. acquired a new stake in Beauty Health in the 3rd quarter valued at $97,000. Finally, Kestra Private Wealth Services LLC increased its stake in Beauty Health by 40.8% in the 3rd quarter. Kestra Private Wealth Services LLC now owns 15,887 shares of the company’s stock valued at $96,000 after buying an additional 4,600 shares during the last quarter. 93.26% of the stock is owned by institutional investors.

Beauty Health Price Performance

SKIN opened at $2.64 on Thursday. The company has a fifty day moving average price of $3.52 and a two-hundred day moving average price of $3.18. The company has a debt-to-equity ratio of 10.51, a quick ratio of 5.55 and a current ratio of 6.57. Beauty Health has a 52 week low of $1.35 and a 52 week high of $10.60. The firm has a market capitalization of $325.86 million, a PE ratio of -3.77 and a beta of 1.13.

Beauty Health (NASDAQ:SKIN) last released its earnings results on Thursday, May 9th. The company reported ($0.10) EPS for the quarter, topping analysts’ consensus estimates of ($0.14) by $0.04. Beauty Health had a negative net margin of 20.48% and a negative return on equity of 0.02%. The firm had revenue of $81.40 million during the quarter, compared to analyst estimates of $80.56 million. During the same quarter in the previous year, the business earned ($0.17) EPS. The business’s quarterly revenue was down 5.7% compared to the same quarter last year. As a group, analysts anticipate that Beauty Health will post -0.03 earnings per share for the current year.

About Beauty Health

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.